Medera Inc. ('Medera'), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing next-generation therapeutics, today announced that positive interim data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback